News
Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
12+ hour, 38+ min ago (391+ words) Servier All the news from Servier - Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine approaches for patients across the world. - Servier strengthens its…...
Symbols: btc-usd,nasdaq:lnai,4568.0